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1. Introduction 
Radiation toxins induce high toxicity reactions after exposure 
Acute Radiation Disease (ARD) or Acute Radiation Syndromes (ARS) are defined as the 
collective toxic clinical states observed from the acute pathological processes in various 
doses of irradiated mammals; to include: systemic inflammatory response syndrome (SIRS), 
toxic multiple organ injury (TMOI), toxic multiple organ dysfunction syndromes (TMODS), 
and finally, toxic multiple organ failure (TMOF). [2, 10, 18, 21 ] Moderate and high doses of 
radiation induces necrosis of radiosensitive cells with the subsequent formation of radiation 
toxins and their induced acute inflammatory processes. Radiation necrosis is the most 
substantial and most severe form of radiation induced injury, and when widespread, has 
grave therapeutic implications [1, 3, 53]. Low doses of radiation exposure induces apoptosis 
(controlled, programmed death of radiosensitive cells) without significant levels of specific 
radiation-induced toxin formation and with only low levels of inflammatory response [17, 
50, 62]. 
Studying the trigger mechanism for radiation-induced lymphocyte death, N.I. Sorokina 
used the results of numerous experiments to show that ionizing radiation induces changes 
in the antigen phenotype of immature thymocytes in mice. This has the same type of effect 
as chemical differentiation inductors and thymotropin, which indirectly attests to the 
specific modifying effect of ionizing radiation [97, 98]. 
B.D. Zhivotovskiy described radiation-induced apoptosis and demonstrated a quantitative 
association between the pyknotic changes in the cell nuclei of thymocytes and production of 
postradiation chromatin decay products. The enzyme responsible for the decomposition of 
chromatin in irradiated cells is Ca/Mg-dependent endonuclease. Areas of endonuclease 
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attack are distributed randomly and are not associated with the level of repetition of 
nucleotide sequences of DNA or the transcriptional activity of chromatin. This supports the 
conclusion that the radiation death of lymphoid cells and the general biological 
phenomenon of programmed cell death are identical in nature [95, 96]. Apoptosis, 
interphase cell death of irradiated lymphocytes, is considered one example of the biological 
phenomenon known as “programmed cell death”. Interphase cell death occurs as the result 
of “switching on” a specific genetic program, the triggering of which evokes induction of 
specific genes that switch on the “cell-death program”. [1] Apoptosis may occur as the result 
of many signals, among which include: various types of lympholytic agents, different 
chemical agents, and physical factors which include ionizing radiation [15,50]. 
But relatively high doses of radiation could induce other forms of programmed cell death, 
apoptosis and/or necrosis. Necrosis especially, initiates inflammation and formation of 
specific Radiation Toxins (RTs) [62, 64, 65, 66, 89, 90, 91]. Specific Radiation Toxins are 
playing an important role as the trigger mechanism for inflammation, cell lysis, and damage 
to vital cellular structures such as mitochondria, DNA, ion channels and cell membranes [89, 
90, 91, 92, 93, 94]. The mechanism and action of Radiation Toxins could be compared to 
actions of different microbial toxins, snake and scorpion venoms, enteric bacterial toxins, 
natural and plant-borne toxins [6, 86, 87, 88]. At high doses of radiation, specific Radiation 
Toxins play an important role in the development of pathological processes, especially 
injury to the central nervous system [ 89, 90, 91]. Radiation induces changes in concentration 
of many chemical mediators which possess significant influence on the Central Neural 
System – acethylcholine, cholinesterase, adrenergic amines, glutamate, Ǆ-Aminobutyric acid, 
aspartic acid and interact with receptors and ions channels.[4, 30]. Many natural toxins like 
scorpion venom induce a prolongation of action potentials caused by selective inhibition of 
sodium current inactivation and specifically affect voltage-gated sodium channels in 
excitable tissues.[ 6, 29, 36, 44, 49, 60, 82, 83, 84, 85 ]. “Excitotoxicity” is an important 
pathological mechanism which damages the central nervous system [27,105]. After high 
doses of radiation, some specific receptors such as the NMDA receptor and AMP receptor 
are over activated. “Excitotoxins” such as NMDA and kainic acid, which bind to these 
receptors, as well as pathologically high levels of glutamate, can cause excitotoxicity, by 
allowing high levels of calcium ions to enter the cell. Ca++ influx into cells activates a 
number of enzymes, including phospholipases, endonucleases, and proteases such as 
calpain. These enzymes go on to damage cell structures e.g. components of the cytoskeleton, 
membranes, and DNA. Excitotoxicity may be involved in stroke, traumatic brain injury and 
neurodegenerative diseases of the central nervous system (CNS) such as multiple sclerosis, 
Alzheimer's disease, amyotrophic lateral sclerosis (ALS), fibromyalgia, Parkinson's disease, 
and Huntington's disease.[27, 105]. It therefore seems logical that exicitotoxicity possibly 
plays a prominent role in CNS injury. 
We also postulate that specific Radiation Neurotoxins damage cerebral blood vessels and 
can induce activation of specific neurotransmitters which may produce exitotoxicity and 
its consequences [100, 103, 104]. The general toxicity of different types of ionizing 
radiation is associated mainly with a formation of Specific Radiation Toxins - a group of 
Radiation Toxins (RT) – Specific Radiation Determinants (SRD). [100, 103, 104]. Radiation 
toxins concentrate initially in intercellular fluid then disperse into blood and lymph and 
thereby induce development of systemic injury of hematologic and lymphatic systems. 
The toxicity of RT SRD subsequently distributes to the cerebrovascular, cardiovascular, 
and gastrointestinal systems, depending on the magnitude o the exposure. The injury to 
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cellular components of radiosensitive and pluripotent hematopoietic and other stem cells 
are induced by processes that are specific for different form of ARS. [100, 103, 104 ]. 
Radiation Toxins: The specific Radiation Toxins (group SRD) are composed from 
glycoproteins with high enzymatic activity including high proteolytic, lipidolytic, 
carbohydratelytic properties. RT are formed and accumulated in mammalian cells and 
migrate into blood and lymphatic circulation in the first hours after irradiation. Radiation 
Toxins, for the most part, are glycoproteins, pro-enzymes which are activated after 
relatively high doses of irradiation, i.e. after some radiation threshold for activation is 
exceeded. This group of glycoproteins has been isolated from cells of irradiated 
mammalian organisms, and possess the ability to induce inflammatory reactions, 
apoptosis, and necrosis similar to reactions mediated by radiation itself. The molecular 
weight of RT (SRD-group) range from 200-250 kDa. The SRD molecules have been isolated 
from blood, lymph and cells of irradiated animals but lymph has the highest 
concentrations measured. Irradiated animals develop the different forms of Acute 
Radiation Syndromes such as Cerebrovascular ARS, Cardiovascular ARS, Gastrointestinal 
ARS, depending on the level of radiation they were exposed to.  
 
Acute 
Radiation 
Syndromes 
Type of 
Radiation 
Toxins 
Grade ARS 
Mild 
Grade ARS 
Moderate 
Grade ARS 
Severe 
Grade  
ARS 
Extremely 
Severe 
Cerebral  
form of ARS 
cerebro-
vascular 
R.T.  
SRD-1.1 SRD-1.2 SRD-1.3 SRD-1.4 
Cardio-
vascular  
form of ARS 
cardio-
vascular  
R.T. 
SRD-2.1 
 
SRD-2.2 SRD-2.3 
 
SRD-2.4 
Gastro-
intestinal  
form of  
ARS 
gastro-
intestinal 
R.T. 
SRD-3.1 SRD-3.2 SRD-3.3 SRD-3.4 
Hematological 
form of  
ARS 
hemato-
poietic  
R.T. 
SRD-4.1 SRD-4.2 SRD-4.3 SRD-4.4 
 
Table 1. Classification of radiation toxins (SRD group): Radiation Toxins are composed of 
toxic substances isolated from lymph of irradiated animals with different forms of Acute 
Radiation Syndromes.  
RT Properties- In our experiments RT were isolated from central lymphatics of irradiated 
animals with different form of ARS and each of the RT possess differences in their 
radiomimetic properties. Cerebrovascular RT, and to a lesser extent, cardiovascular RT and 
gastrointestinal RT are neurotoxins. Hematopoetic RT – are strong hematotoxins. 
Hematopoetic RT can destroy red blood cells and initiate hemolysis, disrupt the blood 
clotting system and cause multi-organ degeneration and tissues damages. Hematopoietic RT 
possess important activity against pluripotent stem cells and blood marrow.  
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Component  
(%) 
Toxic 
substance 
SRD-1 
Toxic 
substance 
SRD –2 
Toxic 
substance 
SRD-3  
Toxic 
substance 
SRD-4. 
Protein 44.9 ± 0.05 48.2 ± 0.03  
 
50.1± 0.09  
 
56.2 ± 0.12  
Lipid 40.1± 0.04  
 
39.6 ± 0.05  
 
38.2± 0.04  
 
30.1± 0.09  
 
Carbohydrate 13.4 ± 0.09  11.3 ± 0.07  
 
10.2 ± 0,03  10.1 ± 0,07  
 
Mineral residue 
 
1.6 ± 0.07  0.9 ± 0.02  1.3 ± 0.04  3.4± 0.17  
Table 2. Biochemical composition of the toxic substances comprising Radiation Toxins. 
(SRD- Specific Radiation Determinants) 
2. Material and methods 
These studies were conducted at several different research institutions and laboratories 
listed as follows: Biotechnology Centre of Russian Academy of Science (North Osetia), 
Kazan All-Union Scientific Research Veterinary, Institute Belarussian Scientific and Research 
Institute for Radiobiology in Gomel, the St. Petersburg Veterinary Institute, the Advanced 
Medical Technology and Systems Inc., Ottawa-Richmond Hill, Ontario, Canada. The studies 
were approved by the Animal Care and Use Committee for ethical animal research 
equivalent, at each institution. A largest volume of purified Radiation Toxin was prepared 
from larger mammalian irradiated animals. Subsequently the RT were characterized 
chemically and biologically. The experimental design of later studies compared relative 
toxicity, potential for development of acute radiation syndromes, and potential lethality 
after intravenous or intramuscular injections of SRD containing Radiation Toxins. More 
recent studies focused on the immunogenicity of small doses of SRDs and the potential to 
use these agents as vaccine countermeasures against radiation injury. 
2.1 Experimental animals 
These experiments have employed a wide variety of experimental and agricultural animals 
which include : Black motley cattle, 2.5-3.0 years of age, live weight of 300-350 kg (n=134); 
Ukrainian pigs, 0.5-1.0 years of age, live weight 35-90 kg (n=142); “prekos” sheep, 3-12 
months old, live weight 18-23 kg (n=156); mixed breed (mongrel) dogs, 2-4 years of age, live 
weight 6.0-6,5 kg (n=162), Chinchilla rabbits, 11-12 months old, live weight 3.5-3.7 (n=180), 
Latvian draft horses, 3-8 years of age, live weight 350-550 kg (n=32), Balb mice, 2-3 months 
old, live weight 20-22 g (n=2636), Wistar rats, 3-4 months old, live weight 180-220 g 
(n=4002).  
In all animals, the pre-experiment blood profiles, body temperature, central venous and 
lymphatic pressure did not exceed the limits of normal variability, (which had been 
previously measured for five species of mammals. Throughout the entire period of each 
experiment, ranging from 1 day to 2 years, the control and experimental animals were 
maintained under identical conditions of feeding, housing, and care, corresponding to 
livestock maintenance requirements and standards. 
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2.2 Electromagnetic radiation exposure 
The animals were irradiated in RUM-17, Puma, and Panorama devices. The dose rate varied 
from 30Gy to 100Gy 
2.3 Experimental design 
Four independent experiments were performed with administration (IV or IM) of Radiation 
Toxins (SRD RT) to healthy, radiation naive animals that induced development of clinical 
symptoms of the Acute Radiation Syndromes. The administration of injection of the toxin 
was administered into veins (IV), into a muscle (IM), into the abdomen (IP) or into the  
skin (SC).  
Experiment N1. Administration of Cerebrovascular form of Radiation Toxins to radiation 
naive animals in doses 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg up to 30 mg/kg 
initiates development of specific toxic reactions with symptoms mimicking the cerebral form 
of ARS. Injection of Cerebrovascular Radiation Toxins (SRD-1) in excess of 3 mg/kg doses to 
rats, rabbits, sheep resulted in lethality.  
Experiment N2. Administration of radiation toxins of Cardiovascular Radiation Toxins 
(SRD-2) to radiation naive animals in doses 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 
mg/kg up to 30 mg/kg produced specific toxic reactions with symptoms mimicking the 
Cardiovascular form of ARS.  
Experiment N3. Administration of Gastrointestinal Radiation Toxins (SRD-3) group 
to radiation naive animals in doses 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg up 
to 30 mg/kg produced development of specific toxic reactions with symptoms mimicking 
the GI form of ARS.  
Experiment N4. Administration of Haemotopoietic Radiation Toxins (SRD-4) to radiation 
naive animals in doses 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg up to 30 
mg/kg produced specific toxic reactions with symptoms of the hematological form of 
ARS.  
2.4 Radiation toxins description and isolation 
The methods of immune depletion, affine immuno-lympho-plasmasorption, as well as 
direct extraction were used to refine and purify the specific Radiation Toxins from the 
central lymph of animals with Cerebrovascular, Cardiovascular , Gastrointestinal and 
Haemotopoietic forms of Radiation Toxins.[104, 110] 
Specific Radiation Determinants (SRD)- a group of Radiation Toxins isolated from lymph 
of irradiated mammals, had been divided to four important groups: 1.Cerebrovascular 
neurotoxic RT (SRD-1); 2.Cardiovascular RT(SRD-2); 3.Gastrointestinal RT (SRD-3); 
4.Hematopoetic RT (SRD-4). The radiomimetic properties of Radiation Toxins 
preparations were evaluated on the basis of their capacity to induce radiobiological effects 
in radiation-naive animals after they were administered parenterally. Specific 
Cerebrovascular, Cardiovascular, Gastrointestinal and Hematopoietic Toxins (isolated 
from the lymph of animals irradiated at doses inducing Cerebral, Cardiovascular, 
Gastrointestinal and Haemotopoietic clinical forms of ARS) were dissolved in an isotonic 
solution of NaCl. The doses of preparations of Radiation Toxins which were administered 
was based on computation of the amount of SRD per unit volume of central lymph and 
absorbed dose of radiation. Radiation toxins of SRD group possess highly toxic properties 
and induce neuro-vascular and hematotoxic reactions in short time after administration. 
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Neurotoxins of SRD-1 group isolated from L.S. (lymphatic system) of irradiated animals 
with Cerebrovascular ARS after intra-muscular or intra-venous single injection in doses 5 
mg/kg, 10 mg/kg, 15 mg / kg, 30 mg/kg activate acute neuro-vascular reactions with 
signs of injury of central and peripheral nervous system and damage of vascular walls of 
central nervous system. 
Neurotoxins of SRD-2 group isolated from L.S. of irradiated animals with cardio-vascular 
form of ARS after intra-muscular or intra-venous single injection in doses 5 mg/kg, 10 
mg/kg, 15 mg/kg, 30 mg/kg activate acute cardio-vascular and neuro-vascular reactions 
with signs of injury of central and peripheral vascular system . Neurotoxins of SRD-3 group 
isolated from L.S. of irradiated animals with gastro-intestinal form of ARS after intra-
muscular or intra-venous single injection in doses 5 mg/kg, 10 mg/kg, 15 mg/kg and 30 
mg/kg induce acute gastrointestinal syndrome with signs of injury of vascular system of 
gastro-intestinal system and injury of epithelium of intestinal walls. Hematotoxin of SRD-4 
isolated from L.S. of irradiated animals with Hematopoetic form of ARS after single dose 
injection with doses 5 mg/kg, 10 mg/kg, 15 mg/kg, 30 mg/kg activate hematotoxic 
reactions with activation red blood cells and white blood cell lysis and activation of 
apoptosis of hematopoietic cells progenitors. 
3. Results  
SRD-1 Radiation Toxins induced injury of Central Nervous System and development of 
Acute Cerebrovascular form of Radiation Syndrome 
The Cerebrovascular form of Radiation Toxins SRD-1) were administered to radiation 
naive animals in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 
10 mg/kg, 15 mg/kg and 30 mg/kg. The injection of Cerebrovascular Radiation Toxins 
(SRD-1) to rats, rabbits, sheep produced bioeffects similar to the cerebrovascular form of 
ARS. (see Table 3) After parenteral administration, the animals experienced a short period 
of extreme agitation, followed by a deep coma, with alterations in breathing patterns and 
subsequently cardiovascular collapse. The results of autopsy of their bodies 
demonstrated cerebral hemorrhagic strokes, cerebrospinal fluid with blood (reddish 
color), hemorrhagic lesions in brain tissue. Internal organs were filled with blood. 
Multiple petechiae were observed on serous membranes. Depending on doses of 
cerebrovascular Radiation Neurotoxins, death was registered in 15 min or up to 5 hours 
after injection.  
Case #1: The species studied in the experiment- 4 month old lambs. Radiation neurotoxin 
(SRD-1) in single dose of 5 mg/kg of weight was administered intramuscularly to radiation-
naïve sheep. The injected animals were dead within 20 minutes after injection, with a 
profound clinical picture of cerebrovascular ARS, Within 5 minutes there was central 
nervous excitation and nervousness, and within 15 minutes there were signs of coma, 
followed by death. Post-mortem histopathology revealed: Brain- red discoloration of 
cerobrospinal fluid (CSF) with inflammatory meninges; multiple petechiae and hemorrhage 
on meninges surfaces. Grey matter of the brain – hemorrhages. Liver- dark-red coloration, 
with multiple petechiae and hemorrhages. Kidneys- multiple petechiae and hemorrhages. 
Clinical Diagnosis: Acute Cerebrovascuar Shock / Acute Cerebrovascular form of ARS 
induced by single injection of radiation neurotoxin  
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Radiation 
Toxins 
Symptoms Toxic doses  
5mg/kg 
Toxic doses 
10mg/kg 
Toxic doses 
15mg/kg 
Toxic doses 
30 mg/kg  
Cerebrovascular 
Neurotoxin 
SRD-1.  
Cerebral edema, 
hemorrhagic 
stroke  
Death in one 
–three hours  
Death in one 
hour 
Death in 
15-30 min 
Death in 15 
min 
Cardiovascular 
SRD-2.  
Cardiac 
insufficiency, 
hemorrhagic 
stroke. 
 
Death in 
three days 
 
Death in 14 
hours 
 
Death in 7 
hours 
 
Death in 2 
hours 
 
Gastro-Intestinal 
SRD-3. 
 
Vomiting, 
diarrhea, 
hematochezia 
and melana. 
Death in 10-
15 days 
Death in 5-7 
days 
 
 
Death in 2-
3 days  
Death in 24 
hours 
 
 
 
Hematopoietic 
SRD-4 
Peripheral 
edema, 
ecchymosis, 
anemia, 
granulocytopeni
c fevers. 
Death in 2-4 
weeks. 
Death in 
next 10 days. 
Death in 
next 7-10 
days. 
Death in 
next 4-5 
days. 
Mixture of 
lower doses of 
toxins SRD 
1+2+3+4 
 
Cerebral edema, 
vomiting, 
hemorrhage, 
cardiac 
insufficiency. 
Death in 4-5 
hours 
Death in 1-3 
hours 
Death in 
one hour 
Death in 
one hour 
Table 3. Radiation Toxins: Toxic properties of Radiation Toxins (SRD Group 1-4 ) after single 
injection and different forms of Acute Radiation Syndromes induced by each.  
SRD-2 Radiation Toxins induced injury of the Cardiovascular System and development 
of symptoms mimicking the Acute Cardiovascular Radiation Syndrome 
The Cardiovascular form of Radiation Toxins were administered to radiation naive animals 
in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 mg/kg, 15 
mg/kg and 30 mg/kg. The injection of Cardiovascular (SRD-2) RT in toxic doses to 
rats, rabbits, sheep produced symptoms similar to the cardiovascular form of ARS. (see 
Table 3) In this experiment, the following symptoms were observed: a delayed, shorter 
duration and less extreme period of agitation than with SRD-1 RTs, followed by tachycardia, 
cardiac arrhythmias, tachypnea. Postmortem histopathological analysis revealed 
inflammatory changes in the cardiac muscle tissue.  
Case #2: Species in experiment- 4 months old lamb. Radiation neurotoxin (SRD-2) in single 
dose 5 mg/kg of weight was administered intravenously. 14 hours after injection all the 
injected lambs were dead after with a clinical picture of cardiovascular shock: agitation, 
fever, agitation, tachycardia, arrhythmias, hypotension, hyperventilation, followed by 
lethargy, signs of coma and death. Post-mortal histopathology showed: Heart- damaged 
microvasculature, cardiac vasoconstriction , ischemic myocardium, contraction band 
necrosis, multiple cardiac hemorrhages. Kidneys: multiple petechies of haemorrhages, acute 
tubular necrosis and renal failure.  
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SRD-3 Radiation Toxins induced injury of the Gastrointestinal System and development 
of symptoms mimicking the Acute Gastrointestinal Radiation Syndrome 
Administration of Gastrointestinal Radiation Toxins (SRD-3) were administered to radiation 
naive animals in doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 
mg/kg, 15 mg/kg and 30 mg/kg. Injection of SRD-3 in toxic doses to experimental animals 
produced different grades of the Gastrointestinal form of ARS. (see Table 3) Case #3: 
Experimental species: one year old sheep. After a single dose injection of 15 mg/kg of the 
SRD-3 Gastrointestinal radiation toxins (isolated from central lymph of animals with the 
gastrointestinal form of ARS) intravenously, the animals elicit the following: Clinical signs- 
decrease in appetite and increased peristalsis within hours after injection, followed by 
severe diarrhea, hematochezia, dehydration, and later followed by collapse over several 
days. Death occurred 5-10 days after toxin administration. Histopathology revealed- local 
vasoconstriction, damaged microvasculature, large vessel vasodilatation and hyperemia of 
the small bowel and colon. Hypertension was manifested approximately two hours after 
intravenous injection. Ultimately hypotension developed after days of vomiting, diarrhea 
and dehydration.  
SRD-4 Radiation Toxins induced development of Acute Hematopoietic Acute Radiation 
Syndrome 
The Hemotopoietic Radiation Toxins (SRD-4) were administered to radiation naive animals in 
doses of 0.1 mg/kg; 0,5 mg/kg; 1 mg/kg; 2 mg/kg; 3 mg/kg, 5 mg/kg, 10 mg/kg, 15 mg/kg 
and 30 mg/kg. Injection of SRD-4 to experimental animals resulted in erythrocytopenia, 
lymphocytopenia, leukocytopenia, and thrombocytopenia within days to weeks after injection. 
(see Table 3) The development of clinical features of the Acute Hemotopoietic Syndrome 
depended on the dose of SRD-4 Hematopoietic Radiation Toxins injected to radiation naïve 
animals. Autopsy of those animals that died showed acute or chronic hematotoxic reactions. 
The clinical signs were: short-term agitation within 2 hours after administration accompanied 
by a short-term leukocytosis which gave way to a progressive, profound leukopenia, mainly 
attributable to a decrease in the absolute number of lymphocytes, the minimal levels of which 
were measured between days 7 and 15 after injection. Total WBC was 1.2-1.6 1000/μl to 0.4-0.5 
thousand/μl in sheep and 1.8-2.5 thousand/μl to 0.5-0.7 thousand/μl in cattle. The recovery of 
absolute and relative levels of leukocytes and lymphocytes was observed in some animals 
between days 30 and 60. Blood counts exhibited thrombocytopenia accompanied by 
progressive erythrocytopenia, which developed into profound anemia. An extensive blood 
analysis of the peripheral blood of the cattle showed that the processes induced by the SRD-4 
injection and the processes occurring after irradiation were nearly identical. Analysis of the 
clinical reaction to SRD-4 administration, which was assessed on the basis of body 
temperature, and heart and respiration rate, established that all experimental animals showed 
reactions of the same type for all the tested doses and that sheep and horses were more 
sensitive to the administered preparation. Thus, in sheep, which received SRD-4 at the 
maximum dose tested, the body temperature increased by 1.5-2 ° C, reaching 41.2° 1 or 2 days 
before death. This core body temperature increase was accompanied by severe tachycardia 
and tachypnea, which were measured at 105-106/min. and 70-80/ minute, respectively. When 
SRD-4 was administered in the intermediate and maximum dose levels, both sheep and cattle 
showed changes of the same type but of lesser degree depending on the dose. The majority of 
experimental animals recovered between days 30-60 after injection of the preparation. Post-
mortem examination of the animals that died showed changes characteristic of acute radiation 
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sickness, accompanied by marked hemorrhage. Death often will occur secondary to 
overwhelming bacterial or fungal sepsis. Some sheep showed areas of skin epilation on the 
back and abdomen.  
Case# 4. Species- sheep. Hematoxin, SDR-4, isolated from irradiated mammals with the 
Hematopoietic form of ARS, was injected via single dose to non-irradiated mammals. The 
SRD-4 RT induced significant changes in white blood cells (WBC) and red cells profile 
(RBC). Hematoxin injected to non-irradiated sheep in doses 5 mg/kg, 10 mg/kg, 30 mg/kg 
activated a complex reaction which included general inflammation, vascular endothelial cell 
injury, apoptosis and necrosis of blood progenitor/ stem cells. The levels of sheep 
erythrocytes, leukocytes, lymphocytes, thrombocytes significantly increased in first hours 
and day after single injection of radiation hematotoxin and could be a result of general 
inflammation reactions and stimulation of immune system. However the levels of 
erythrocytes, leukocytes, lymphocytes, thrombocytes significantly decreased after 72 hours 
after hematoxin administration and the minimal level of erythrocytes, leukocytes, 
lymphocytes were measured after 168- 360 hours following a single dose injection of the 
radiation-induced hematoxin. (see Tables 4- 7) Characteristics of the peripheral blood of 
large horn cattle after a single injection of Hematopoetic Radiation Toxin (SRD-4) were 
measured and levels of erythrocytes, leukocytes, lymphocytes significantly increased in first 
hours after a single dose injection of radiation hematotoxin and decreased after 72, 168, and 
360 hours after administration. (see Tables 8- 11) 
 
 
 
Fig. 1. Dose-dependent changes in sheep peripheral blood erythrocytes after a single 
injection of Hematopoietic Radiation Toxin (SRD-4). 
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Fig. 2. Dose-dependent changes sheep peripheral blood leukocytes after a single injection of 
Hematopoietic Radiation Toxin (SRD-4). 
 
 
Fig. 3. Dose-dependent dynamics of sheep Lymphocytes after single IV administration of 
Hematotoxin (SRD-4).  
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Fig. 4. Dose-dependent dynamics of sheep thrombocytes (platelets) after single IV 
administration of Hematotoxin (SRD-4).  
 
 
Fig. 5. Dose-dependent characteristics of large horn cattle peripheral blood erythrocytes 
after single injection of Hematopoetic Radiation Toxin (SRD-4).  
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Fig. 6. Dose-dependent changes in cattle peripheral blood leukocytes after a single injection 
of Hematopoietic Radiation Toxin (SRD-4). 
 
 
Fig. 7. Dose-dependent dynamics of cattle Lymphocytes after single IV administration of 
Hematotoxin (SRD-4). 
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Fig. 8. Dose-dependent dynamics of cattle thrombocytes (platelets) after single IV 
administration of Hematotoxin (SRD-4). 
4. Discussion 
Radiation toxin SRD-1 (cerebrovascular radio-neurotoxin) activates pathophysiological 
processes and clinical symptoms / signs of central and peripheral nervous system injury 
with development of neurological and cognitive deficit, activation, followed by depression, 
of specific centers of the central nervous system, including autonomic nervous system 
pathways.  
Radiation toxin SRD-2 (cardiovascular radiotoxin ) activates pathophysiological processes 
and clinical symptoms / signs of cardiac and vascular inflammation and injury with 
endothelium cell, microvascular vessel and cardiovascular system tissue showing apoptosis 
and necrosis. Severe hypotension and tachycardia were important clinical indicators of 
cardiovascular acute radiation syndromes with the subsequent development of cardiac 
myocyte necrosis.  
Radiation toxin SRD-3 (gastrointestinal radiotoxin) initiates symptoms signs of 
gastrointestinal system injury including anorexia and vomiting, induced by the toxic effects 
and damage to the vascular and lymphatic vessel network of the gastrointestinal system, as 
well as apoptosis of intestinal lining epithelial cells, including crypt / villi necrosis. Severe 
diarrhea and melena / hematochezia were important clinical indicators of the mimicked 
gastrointestinal acute radiation syndrome.  
Radiation toxin SRD-4 (hematotoxin) induces development of red cell lysis and apoptosis of 
white blood cell and red cell progenitors. The action of the SRD-4 hematotoxin is described 
0
50
100
150
200
250
300
350
400
450
norm 12 hours 72 168 360 720
30 mg/kg
15 mg/kg
5 mg/kg
www.intechopen.com
 
Current Topics in Ionizing Radiation Research 228 
in Tables 4-7 for sheep and 8-11 for cattle. Thrombocytopenia, lymphocytopenia, 
granulocytopenia , ecchymosis, hemorrhage and coagulopathy were important clinical signs 
of the mimicked hematopoietic acute radiation syndrome.  
Other clinical indicators of the Radiation Toxins (RT) included cutaneous system 
involvement: including: cutaneous edemas, blustering, desquamation, hair loss, ulcer and 
necrosis.  
Severe Acute Radiation Exposure sydromes will induce Toxic Multiple Organ Failure 
(TMOF) and Toxic Multiple Organ Involvement (TMOI) – e.g. pneumonitis, renal failure, 
renal hypo-perfusion, acute tubular necrosis, hepatic failure, etc. as an acute consequences 
of radiation toxemia. Similarly, bacterial toxemia induced by bacterial superantigens and 
radiation-induced toxemia are very similar in their clinical manifestation and similar in their 
pathophysiological actions. In a related matter, the molecular structure of radiation antigens 
(toxins) and bacterial superantigens, as well as different snake venom toxins have 
similarities. 
Thus, if a researcher administers specific Radiation Toxins of one of the SRD groups to 
radiation naive animals, toxicity will be observed along a dose response curve, from doses 
as small as 0.1 mg/kg or 0.5 mg/kg up to the highest tested dose of 30 mg/kg. The observed 
toxicity will mimic the ARS syndrome specific to the exposure of the animals from which 
the SRDs were acquired. Thus the exogenously administered SRD initiates development of 
specific toxic reactions with symptoms of a specific ARS, hence the name-specific radiation 
determinant (SRD 1-4). The SRD-group molecules possess both toxic and antigenic 
properties. The molecular Koch’s postulates, which are commonly applied to bacterial toxin 
pathogenecity, could also be applied to the biological effect produced by Radiation Toxins, 
and those postulates would mostly be satisfied to list RT as the causative agents [101, 106].  
4.1 Comparative analysis of bacterial toxins vs radiation toxins (see table 12) 
We compared lethal toxicity and clinicopathological features and characteristics for 
Radiation Toxins and Bacterial Toxins. Pathogenic bacteria which colonize the intestine, can 
invade intestinal epithelial cells and lymphatics, and/or produce one or more toxins that are 
important etiologies of diarrheal disease [32, 42, 48, 57, 86, 87, 88]. Bacteria produce toxins 
and the mechanisms of action of bacterial toxins can be classified into three important 
groups (see Table 12) : 1. Toxins with intrinsic enzymatic activity – cytotoxic bacterial toxins. 
2. Toxins that binds to receptors that stimulate the actions of second messengers – cytotonic 
bacterial toxins (e.g. botulinum or cholera toxins) . 3. Toxins that damage eukaryotic cell 
membranes – membranotoxic bacterial toxins. [32, 42, 48, 57, 86,]. We postulate that 
radiation toxins possess high enzymatic activity, damage cell membranes, and also activate 
cell receptors. We postulate that radiation toxin mechanisms of action depend on the toxin 
type and dose of radiation toxins. We postulate that Radiation Toxins could initiate two 
different types of cell death – programmed (apoptosis) or necrosis. [90,91]. 
Escherichia Coli is an Enteric Gram-negative rods and their pathogenic strains contained the 
wide group of toxins with different properties. Escherichia Coli contain endotoxin - 
lipopolysaccharide, which is antigenic and virulence factor. [12, 48]. Escherichia Coli contains 
three groups of antigens – O, H and K. The O antigens – cell wall antigens - found in 
polysaccharide portion of LPS. The H antigens are associated with flagella and the K antigens 
are associated with the fimbriae or capsule. [12,48,78,79,87,88 ]. Enteroaggregative E.Coli –
EAEC, produce three important toxins. EAEC heat stable enterotoxin is a 4.1-kDa protein. The 
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other EAEC heat -liable enterotoxin with molecular weight 120 kDa. The third EAEC 
enterotoxin is a heat liabile,108 kDa protein with the ability to induce a severe acute intestinal 
inflammation. [12,78,79,87]. Enterohemorrhagic Escherechia coli, EHEC contains a Shigella-like 
toxin. The Shiga toxin family contains Shiga-like toxin 1 (SLT-1) and Shiga-like toxin 2 (SLT-2). 
EHEC strains produce SLT -2 or combination SLT 1 and SLT 2 [12 ]. Shiga toxin is a cytotoxic 
for endothelial and epithelial cells including human colonic and ileal epithelial cells, and B-
lymphocytes [12]. Enteropathogenic Echerechia coli induce an important and distinctive 
histopathologic lesion in the intestine with destruction of microvilli – the classic 
histopathologic lesion - AE lesion [12 ]. There are two proteins responsible for development 
AE lesion – a 94-kDa protein and protein encoded by the eaeB gene. [12,78,79].  
 
Toxins Mechanism of Action Symptoms 
1. Enterotoxigenic E. Coli 
(ETEC). 
1. ETEC -  
Three toxins: EA- ST,  
EA- HL, EA-HL 
ETEC toxins induce hyper-
secretion by intestinal mucosa 
cells, watery diarrhea 
2. Enteropathogenic E. Coli 
(EPEC). 
2. EPEC -  
Shiga-like toxins. 
EPEC toxins causing 
destruction of microvilli and 
development focal lesions. 
3. Enterohemorrhagic E. Coli 
(EHEC). 
3. EHEC –  
verotoxin or Shiga-  
like toxin.  
 
EHEC induce severe form of 
hemorrhagic colitis, acute 
renal failure or hemolytic 
uremic syndrome. 
4. Enteroinvasive E. Coli 
(EIEC). 
 EIEC induce dysentery  
like syndrome 
5. Enteroadherent E. Coli 
(EAEC). 
 EAEC cause traveler’diarrhea 
Table 4. Bacterial Toxins and their mechanisms of action. 
Enterotoxigenic Escherechia coli produce heat—stable (ST) and heat-labile enterotoxins (LT). 
STa is a cysteine-rich, 18-amino-acid peptide. ST is produced as a precursor that is cleaved 
by signal peptidase and translocated to the periplasm where is added three intra-molecular 
disulfide bonds crucial for toxin activity. A second proteolytic agent occurs extracellularly 
and produce biologically active and toxic ST [12,81,]. STa acts by binding to a protein 
intestinal epithelial receptor localized in brush border membrane. [12,78].  
E.coli heat-stable enterotoxin b is a 71-amino-acid precursor protein secreted extracellularly 
and proteolytically processed to a toxic form as a 48-amino-acid protein [12, 79]. E. coli heat-
labile enterotoxin I is closely related to CT, including its structure and enzymatic activity. 
[12]. Other Escherechia coli Toxins include Cytolethal distending toxin and Cytotoxic 
necrotizing factors [12, 78,79 ].  
Staphylococcus aureus produces serologically distinct protein exotoxins named A, B, C1, C3, 
D, E. All of these exotoxins are small proteins (24-30 kDa) with important biological 
activities. All seven toxins stimulate local receptors in upper intestinal tracts [12, 86]. 
Staphylococcal enterotoxins are likely playing an important role in cytokine production and 
are most potent T-cell receptor activators and inducers of lymphocyte proliferation. This 
class of toxins could be classified as “superantigens”, as well as the toxins produced by 
Streptococcus spp. and Clostridium perfringens. Superantigens presented directly to the T- 
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Clinical symptoms induced by Bacterial 
Superantigene 
Clinical symptoms induced by radiation 
toxins (SRD group) and by irradiation. 
Central Nervous System involvement  
Peripheral nervous system  
Confusion, Irritability, Lethargy 
CNS involvement: Cerebro-Vascular Acute 
Radiation Syndrome. Radiation Induced 
Neurotoxin. Neurological and Cognitive 
Deficit, Vomiting. Severe form of brain 
microcirculation disorder. Clinical futures of 
hemorrhagic stroke. 
Cardio-Vascular System involvement 
Systolic Blood Pressure :< 90 mmHg 
Tachycardia >100 beats/min, 
Hypotension, Hyperventilation, Loss of 
Sympathetic responsiveness . 
Cardio-Vascular System involvement: 
Cardio-vascular Radiotoxin-induced Acute 
Radiation Syndrome.- Tachycardia, 
Bradicardia, Arrythmias, Hypertension 
followed by severe hypotension  
(Systolic Blood Pressure:< 80 mmHg), 
hyperventilation.  
Gastro-Intestinal System Involvement 
Vomiting, diarrhea, hematochezia and 
stool mucous (depending on which 
enteric toxin). 
Gastro-intestinal System Involvement: 
Gastro-Intestinal Acute Radiation Disease. 
Radiotoxin. Vomiting, diarrhea. Melena and 
hematochezia. Abdominal pain- moderate to 
severe.  
Bacterial Superantigen hematotoxicity 
Thrombocytopenia, Platelet count < 
100,000/mm3.- Thrombocytopenia., 
leukopenia, pancytopenia. Disseminated 
Intravascular Coagulation (DIC) 
Syndrome. 
Hematopoietic Toxicity:  
Acute Radiation Hematopoetic Syndrome. 
Hematopoietic Radiation Toxin- 
Thrombocytopenia, Lymphocytopenia, 
Granulocytopenia. Pancytopenia. 
Cutaneous involvement: diffuse 
maculopapular, petechial or ecchymotic 
rash, intense erythroderma, 
desquamation (e.g. meningococcemia or 
toxic shock syndrome). 
Cutaneous System Involvement: 
Possibleaction of any type of Radiation 
Toxins. Swelling, edema, blustering, 
desquamation, hair loss, ulceration  
and skin necrosis 
Multiple Organ Failure and Multiple 
Organ Involvement. 
Multiple Organ Failure and Multiple Organ 
Involvement. 
Renal failure, Renal hypo-perfusion; 
Oliguria, Acute tubular necrosis  
Renal failure, renal hypo-perfusion,  
Acute tubular necrosis. 
Hepatic failure and inflammation Hepatic failure 
Pulmonary System:  
Hyperventilation with 
Respiratory alkalosis, pulmonary 
hypertension and edema,  
hypoxemia, ARDS 
Pulmonary System:  
Hyperventilation.  
Radiation induced pneumonitis and 
subsequent pneumonia, ARDS. 
Table 5. Comparative analysis of clinical symptoms induced by radiation and/or Radiation 
Toxins – (SRD group 1-4)- induced ARS and those produced by Toxic Shock Syndrome 
induced by Bacterial Superantigene.  
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cell receptors by cells containing major histocompatability complex class II molecules, 
without processing by antigen-presenting cells [32,48,86]. Superantigens (SAgs) are a class of 
antigens which cause non-specific activation of T-cells resulting in polyclonal T cell 
activation and massive cytokine release. The large number of activated T-cells secrete large 
amounts of cytokines (the most important of which is TNF-alpha). [32,86]. SAg stimulation 
of antigen presenting cells and T-cells elicits a response that is mainly inflammatory, 
focused on the action of TH-1 T-helper cells. Some of the major products are IL-1, IL-2, IL-6, 
TNF-ǂ, gamma interferon (IFN-Ǆ), macrophage inflammatory protein 1ǂ (MIP-1ǂ), MIP-1ǃ, 
and also monocyte chemoattractant protein 1(MCP-1). Clinical symptoms / signs induced 
by bacterial Superantigenes include central and peripheral nervous system involvement 
(confusion, lethargy, vomiting, anorexia), involvement of the cardiovascular system with 
development of hypotenison, tachycardia and loss of sympathetic responsiveness. Bacterial 
Superantigenes activate toxic processes within the gastrointestinal system including acute 
vomiting and diarrhea. The important signs and clinical picture of bacterial superantigen 
hematotoxicity with development thrombocytopenia, leukopenia, lyphocytopenia and 
development of coagulopathy. Bacterial Superantigenes could activate injury of cutaneus 
system and diffuse rash, erythrodermia, desquamation. [32,86] Radiation Toxins of SRD 
groups 1-4 can activate similar pathological processes, clinical picture and clinical signs as 
the bacterial superantigent toxicity and the three entities: 1) Acute Radiation Syndromes, 2) 
SRD RT- induced acute syndromes and Bacterial Toxin- induced sepstic reaction and 
toxicity can be compared. (see Table 5)  
4.2 Comparative analysis of toxins produced by venom toxins and radiation toxins 
(see table 6) 
Neurotoxic proteins can be isolated from various snake venoms. These proteins can 
potentially be a mix of neurotoxins ,which attack the nervous system; hemototoxins, which 
attack the circulatory system; plus cytotoxins, bungarotoxins and many other toxins that 
affect the body in different ways [6,29,49,60,61,82,83,84,85]. Almost all snake venom contains 
hyaluronidase, an enzyme that ensures rapid diffusion of the venom into the body of the 
bite-victim [82,84]. Viper venoms from the Elapidae, Hydrophiidae, Atractaspididae, 
Viperidae and Colubridae families contain at least 25 separate classes of biologically active 
compounds, including enzymes and non-enzymatic molecules. Venom- neurotoxins activate 
different reactions with nerve synapse – presynaptic and postsynaptic action; and induce 
anticholinesterase-induced flaccid paralysis. Myotoxins from Venom could induce systemic 
skeletal muscle damage. Hemototoxins induce the development of severe microcirculatory 
injury, damage to vascular membranes, thrombosis or bleeding. [6, 82, 84].  
4.3 Radiation induced apoptosis and necrosis 
Radiation induced Apoptosis and Necrosis as response of eukaryotic cells to influence of 
different types of radiation remain contraversion. Radiation induced cell death by triggering 
apoptosis pathways was described in many articles and supported by many scientists [11, 
15, 17, 39, 51, 52, 53, 54, 55, 56; 57, 58, 59, 62, 63, 74, 75, 76, 78]. However some scientists and 
some institutions described processes developing in irradiated eukaryotic cells as necrosis 
[24;34;38] and some scientists describing a variety of complex mechanism and mentioned 
that radiation-induced cell death could developing under different mechanisms of 
pathogenesis which include and apoptosis and necrosis. [1, 34, 38, 43, 77] Activation of 
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Venom Toxins Mechanism of Action Symptoms 
Polypeptide toxins. Autonomic, 
Neurotoxic, 
Cardiotoxic,  
Myotoxic 
Induce two forms of 
programmed cell death: cell 
apoptosis or cell necrosis. 
Presynaptic or postsynaptic 
actions. Induce excitation of 
some neurons.  
Neurotoxicity, Haemototoxity. 
Phospholipase toxins. Presynaptic neurotoxic, 
myolytic, procoagulant, 
cardiotoxic, necrotic. 
Induce cerebrovascular toxicity, 
cardiovascular toxicity.  
Enzyme toxins: 
Transferases, 
Oxydoreductases, 
Hydrolases, Carbon-
nitrogen lyases, 
Metalloproteinases. 
Disorder of 
haemostasis,  
necrotic,  
haemolytic. 
Blood vessel injury, blood cell 
lysis, brain tissue damage, heart 
muscle damage, liver damage, 
kidney damage. Neurotoxicity. 
Haemototoxicity. Skin damage. 
Hair follicule damage.  
The Group of Toxins: 
Lectins, Nerve growth 
factors, Phospholipase 
inhibitors, Complement 
inhibitors, Proteinase 
inhibitors. 
Cardiotoxic, 
Neurotoxic. 
Anticoagulant proteins.  
Platelet aggregation inducers. 
Platelet aggregation inhibitors. 
Table 6. Venom toxins and mechanisms of action – biochemical and clinical classification. 
cysteine proteases, cleavage of PARP - poly (ADP-ribosyl) ation of nuclear proteins causes 
the inner mitochondrial membrane to become permeable for ions and other small molecules 
during both types of cell death- apoptosis and necrosis. Many mechanisms of cell necrosis 
and apoptosis are identical – for example, degradation of the Nuclear matrix is a Common 
Element during Radiation-Induced Apoptosis and Necrosis [1,3,11,16,24,34,38,43,53,59,78].  
Data from different sources described that the differences between apoptosis and necrosis 
are much less numerous than previously studies suggested. [1,78]. Joseph Dynlacht and his 
research group of scientists studied the outcome of human promyelocytic leukemia (HL60) 
cells irradiated with 10 or 50 Gy of X-rays and determined the mode of leukemic cell death. 
Different doses of X-rays induced different modes of cell death – cells irradiated with 10 Gy 
died by necrosis; cells irradiated with 50Gy died predominantly by apoptosis. [16].  
The Cell Death Nomenclature Committee recommends the use of the appropriate diagnosis: 
apoptotic necrosis. [34]. Comparison and description of a cell’s Necrosis and Apoptosis were 
provided by a group of scientists from different institutions and research groups [16,34]. 
Apoptosis is described as a normally active, programmed process of cell death devoid of 
inflammation and toxins. [16,34]. Necrosis possesses the characteristics of accidental or 
externally-induced cell death from the influence of different environmental factors and 
triggering development of inflammation and elaborating of toxins, release of pro-
inflammatory active and toxic cellular contents into the intracellular and extracellular fluids 
and into the lymphatic systems and blood circulation [39,55,56,62]. Caspases are important 
molecular mechanisms and central components of the apoptosis process [39, 50, 51, 52, 54, 
58, 62, 74, 75, 77, 78].  
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Apoptosis Necrosis 
Inflammation never present.  Inflammation always present. 
Toxic substances never present.  Toxic substances always present. 
Morphologically cells shrinks, become 
denser, condensation occur, original name 
– shrinkage necrosis. Mitochondria’s 
structure and functions are not affected. 
Morphologically cells swelling, lysis.  
Mitochondria’s structure and functions are 
affected. 
Karyorhexis – pyknotic nuclear fragments. 
DNA broken into segments. 
 
Karyolysis, Pyknosis, Karyorhesis. Nuclear 
swelling, Chromatin granular, Chromatin 
flocculation, Types of radiation induced 
damage of DNA: Breaks of the strand, 
alteration to bases, destruction of sugar, 
cross-links and formation of dimmers 
Caspase activation always present. Caspase depended initiation of developing 
of necrosis possible. Caspase-8 initiation 
possible with apoptosis and necrosis.  
Genetic control initiate apoptosis No genetic control, environmentally-
induced 
The Budding phenomenon. 
Cell membrane not affected  
The Blebbing phenomenon, increased 
membrane’s permeability. Cell membrane 
affected by external and internal factors. 
Table 7. Apoptosis and Necrosis: Comparison of Morphological and Biochemical features.   
However, apoptosis is the principal mechanisms by which cells are physiologically 
eliminated. During apoptotic death, cellular dissociation by caspases of cell compartments 
occur and cell compartments and molecules are packaged into apoptotic bodies to avoid 
immune activation. [24,34,78]. Necrosis was considered in past times as passive, 
uncontrolled and unorganized mechanism of cell death. At the present time necrosis is 
considered as an alternative form of programmed cell death whose activation induces 
important biological consequences including immune reactions and induced inflammation. 
[43, 51, 52, 67, 74, 75, 77]. 
4.4 Inflammation induced by radiation 
Radiation induces an important and aggressive inflammatory response in the irradiated 
tissues. [19, 20, 28, 30, 64, 65]. Acute Radiation Disease (ARD) or Acute Radiation 
Syndromes (ARS) were defined as a toxic, poisonous exposure with development of the 
acute pathological processes in irradiated animals: systemic inflammatory response 
syndrome (SIRS), toxic multiple organ injury (TMOI), toxic multiple organ dysfunction 
syndromes (TMOD), toxic multiple organ failure (TMOF) [2, 5, 18, 19, 21, 89, 90, 91]. 
Radiation-induced lung injury, radiation pneumonitis (RP), is a potentially fatal side-effect 
of thoracic radiation therapy [3, 4, 11, 15]. Radiation-induced thyroiditis: can occur after the 
use of radiation treatment and can result in lifelong hypothyroidism [18]. Irradiation of the 
liver with doses of 2,450-2,920 rads caused liver injury in 14 patients of 65 patients treated 
with radiation therapy [3, 28]. The clinical picture of radiation-induced hepatitis includes 
hepatomegaly, ascites, pleural effusion and alteration in liver function. Radiation injury of 
the central nervous system (CNS) has devastating and fatal clinical consequences and 
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severely limits the dose that can be delivered in the radiotherapy of brain, head and neck, 
pulmonary and other tumors [19, 28, 30, 64, 65]. Hematopoetic system toxicity is a major 
limiting factor in the use of aggressive, combined modality therapy (chemotherapy + 
radiotherapy) in the treatment of malignant disease [14, 22, 40].  
Permanent anemia and pancytopenia can be caused by the reduced capability for cellular 
proliferation due to the stem cells injury produced by radiation. [14, 69, 70, 72, 76]. Radiation 
induces an inflammatory response in the irradiated organs characterized by leukocyte 
infiltration and vascular permeability changes and vascular injury [90, 99]. Vascular injury is 
a key determinant of acute and chronic organ intoxication and dysfunction associated with 
irradiation of the different systems, including the gastrointestinal tract [9, 19, 20, 22,]. 
Radiotherapy is used in the treatment of pediatric brain tumors and is often associated with 
inflammation and behavior changing following irradiation-induced inflammation and 
injury in the developing brain [19, 20]. The consequences of irradiation microglial loss can 
be secondary to injury from pronounced inflammation [19, 20]. A prominent inflammatory 
response occurs following both ischemic and hemorrhagic forms of microcirculation 
disorders [19, 20].  
4.5 Roles of radiation toxins in developing of cellular structure radiation-induced 
injury 
Radiation Toxins contained a group of biologically-active compounds which induce 
complicated but specific mechanisms of action with tissues and cellular damage. Radiation 
Toxins include a group of glycoproteins with high enzymatic activity against proteins, 
lipids, carbohydrates. Radiation Toxins contain a group of peptides with selective affinity to 
number of receptors and specific interactions with receptors of mammalian organisms. 
Toxins isolated from the irradiated mammals inhibit or activate a group of an ion channels, 
acetylcholine receptors, nicotinic receptors, membranes, coagulant/anticoagulant pathways. 
Our experiments involved injections to radiation-naïve animals of toxic doses of Radiation 
Toxins (SDR- group) which damaged endothelial cells of blood and lymphatic vessels, and 
injury to blood microcirculation in the brain, lungs, gastrointestinal tract, cardiovascular 
system. Administration (IV or IM) of the Haemotopoietic Radiation Toxins to radiation-
naïve animals induced development of anemia with reduction of hemoglobin concentration, 
reduction of red blood cell count and reduction of white cell blood count. Hemotopoietic 
Radiation Toxins induced the development of hemolytic anaemia with accelerated 
destruction of mature red cells outside the bone marrow and destruction of pluripotent stem 
cells inside of the bone marrow. Radiation-induced hemolytic anemia occurred with 
intravascular and extravascular hemolysis. As a result of stem cell injury erythropenia, 
leukopenia, thropmbocytopenia developed within days after irradiation. However, the 
acute hemolytic extravascular and intravascular anemia with lysis of erythrocytes, 
developed after high doses of radiation.  
4.6 Development of radiation countermeasures 
There are many sources of oxidative stress in the lives of workers, whether they work in 
nuclear power facilities, on the front lines of international conflicts, or in the reaches of outer 
space. The exposure dose can vary substantially, but at minimum will accelerate the aging 
of their organ systems, and at worse could result in acute exposure syndromes that may be 
fatal. A common thread of the oxidative stress exposures is ROS-binding to critical cellular 
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organelles and molecules, which can result in cellular dysfunction, mutation of nucleic 
acids, or even apoptotic cell death [107]. Currently there are no proven countermeasures for 
these exposures, aside from a clinical agent, Amifostine, (Etyhol™), which is used to reduce 
mucositis and other side effects from radiation therapy dose in cancer patients. 
The cytotoxic effects of different types of radiation may be the single most 
important clinicopathologic process by which oxidative damage is induced from reactive 
oxygen species and radiation toxicity induced by radiation toxins. Radiation toxins (SRDs) 
with high enzymatic activity and their ability to degraded a wide variety of extracellular 
proteins, lipids, carbohydrates and DNA molecules, induce damage of important 
intracellular compartments such as mitochondria, ion channels, DNA, as well as activating 
degradation of peptide bonds in important polypeptides in tissues and vascular 
endothelium. Yet the exact mechanism by which radiation toxins stimulate development of 
the ARS is poorly understood. 
Countermeasures against radiation toxicity can be developed both in oral formulas [109] 
and parenteral agents, e.g. Manganese SuperOxide Dismutase (MnSOD)-liposomes [108, 
109] which can reduce radiation exposure-induced biological effects. The oral formulas 
consist of a combination of antioxidants and chemopreventive, anti-progression agents, 
which can reduce the likelihood of mild toxicity in acute low dose radiation exposures and 
tumor induction in chronic low dose exposures. The combination of oral formulas with 
higher dose reactive oxygen species scavengers, like Mn-SOD can improve survival in 
animals exposed to acute high dose total body irradiation [109]. In addition to these 
measures, active immunization by low, non-toxic doses of radiation toxins, (SRDs) can also 
be employed to reduce radiation toxicity. [104, 110] To be effective, SRD immunization must 
occur no less than 30 days before irradiation, and can be effective up to three years or more. 
Active immunization by radiation toxins can significantly improve the survival rate (up to 
60%) versus placebo-controlled irradiated animals. Our studies attempt to show the 
potential ability of specific antibodies to neutralize radiation toxins and thus substantially 
reduce the effects on radiation-induced neuro-, vascular, gastrointestinal, and hematopoietic 
toxicity. [104, 110] Antiradiation antibodies prevent the radiation-induced cytolysis of 
selected groups of cells that are sensitive to radiation. Anti-radiation antibodies derived 
from different phases of the Acute Radiation Syndrome can compete with and thus prevent 
cytolysis mediated by cytotoxic lymphocytes. The therapeutic benefit of neutralization of 
SRD radiation toxins could make hemopoetic stem cell transplantation more effective. 
Antiradiation vaccine and IgG antibodies have shown activity in animals against several 
different types of radiation include gamma, heavy ions, and neutron irradiation.[104, 110] 
Preliminary and pilot studies in vitro, in animal models and recently in humans, are 
showing some promise for both efficacy and safety/tolerability. [108-110] With current 
unpredictability in the operation of nuclear power facilities, potential radio-biologic terrorist 
weapons, and human operations in extreme environments, it is important to develop 
countermeasures to radiation toxicity in order to protect the potentially exposed. The first 
step in developing these countermeasures is to fully understanding the mechanism of 
toxicity, as is attempted to be summarized in this chapter. 
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